The DRAIN-HF study is going international with our first enrollment in Hungary! Congrats to the team at Semmelweis University (@semmelweishu) Hospital on enrolling your first patient in this groundbreaking study for patients with acute decompensated heart failure. We are grateful

📷 𝗦𝗲𝘃𝗲𝗻 𝘀𝘁𝗿𝗼𝗻𝗴!!.Huge congratulations to the powerhouse team at @USFHealth / @TGHCares for reaching their 7th enrollment in the DRAIN-HF trial, making them the top enrolling site to date!. The team's dedication and momentum are setting the pace in this important study

Join millions who have switched to Grok.

Congratulations to the team at @AdventHealth Tampa on reaching their 5th enrollment in the DRAIN-HF pivotal trial!. Each enrollment brings us one step closer to advancing treatment options for patients with acute decompensated heart failure, and we're proud to partner with the

As we continue to make great progress with our DRAIN-HF trial evaluating our investigational Aortix pump, one question we often get is "How does Aortix work?" . To answer that question, we're thrilled to launch our new animation (also available at that

Kudos to the @HFSA for creating a clear and impactful infographic that highlights two of the most persistent challenges in heart failure care: diuretic resistance and unresolved congestion at discharge. At Procyrion, we believe that raising awareness is the first step toward

A HUGE thank you to all the DRAIN-HF sites that enrolled patients in Q2!. Your commitment to advancing treatment options for patients with acute decompensated heart failure is what drives this study forward and inspires the Procyrion team daily. Each patient brings us one step

We're thrilled to welcome the team at Advocate Good Samaritan Hospital to the DRAIN-HF family! Congrats to the incredible team of Drs. Ali Valika, Dominick Bufalino, Owais Malick, Manan Naik, Mahesh Raju, Joseph Venturini and research coordinators Debra Heidenreich, Lynn McLennan

First DRAIN-HF enrollment in Illinois! Congrats to the powerhouse team at the University of Chicago (@UChicago), led by PI Dr. Jonathan Grinstein, implanting physician and DRAIN-HF steering committee member Dr. Sandeep Nathan (@SandeepNathanMD), Dr. Mark Belkin, Dr. Jay

The DRAIN-HF trial continues to gain momentum, with 45 enrolling sites coast to coast. Every site brings us one step closer to generating the clinical evidence we need to make Aortix available for patients with acute decompensated heart failure. This incredible progress is only

We're looking forward to participating in the Heart of The City: HVTI Cardiovascular Symposium hosted by Cleveland Clinic Florida (@CleveClinicFL) this weekend. Stop by the Procyrion table and meet with team members Jace Heuring and Kelly Mesa to learn more about the Aortix

Congratulations to @HenryFordHealth on their 10th Aortix implant! This milestone reflects the dedication and momentum of the Henry Ford team in advancing care for patients with acute decompensated heart failure. We're honored to work with the incredible team of Dr. Mohammad

Terrific article by @scottnelsonlive in @MassDevice about what #medtech leaders should consider when designing clinical trials. Part of the article pulls from an earlier @medsider interview with our CEO Eric Fain where he shares his perspectives on the importance of focusing on.

📣As we close out the first quarter, we want to give a shout out to our top enrolling DRAIN-HF sites. Congrats to the incredible teams at @HenryFordHealth, @Texas_Heart, and @USouthFlorida for leading the way with 5 enrollments each to date! The Procyrion team is inspired

𝗛𝗼𝘁 𝗼𝗳𝗳 𝘁𝗵𝗲 𝗽𝗿𝗲𝘀𝘀! The results from our preclinical door to unloading study are now published in the Journal of Cardiac Failure (@JCardFail). Learn more about the impact of unloading with the Aortix pMCS device on post-AMI infarct size, mortality and hemodynamics.

We're excited to welcome Penn Presbyterian Medical Center (@PennMedicine ) as a new DRAIN-HF site! Congrats to the team led by principal investigator Dr. Hansie Mathelier (@drhansie) and research coordinator Karen Maslowski on their first enrollment!  We look forward to working

Nearly 1/3 of patients with acute decompensated heart failure (ADHF) have cardiorenal syndrome (CRS), where the underlying heart failure leads to reduced blood flow to the kidneys, causing the kidneys to become less effective at removing excess fluid from the body. CRS patients

We're making great progress: 50 patients enrolled to date in the DRAIN-HF trial! Thank you to all the DRAIN-HF investigators, research teams and sites for your commitment to this important study as we work together to advance treatment options for patients with acute

#ICYMI -- The results from Procyrion's Cardiorenal Syndrome pilot study were published in #JACCHF. Check out the publication to learn more about the safety and performance of the Aortix pump in patients with acute decompensated heart failure. #Aortix